SEC Comment Letter for PULSE BIOSCIENCES, INC. (PLSE) (CIK 0001625101) (PLSE) — May 17, 2018
PULSE BIOSCIENCES, INC. (PLSE) (CIK 0001625101)
Date: May 17, 2018 · CIK: 0001625101 · Accession: 0000000000-18-015315
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-224800
Letter
Mail Stop 3030 May 16, 2018 Via E -mail Darrin R. Uecker President and Chief Executive Officer Pulse Biosciences, Inc. 3957 Point Eden Way Hayward, CA 94545
Re: Pulse Biosciences, Inc. Registration Statement on Form S-3 Filed May 9, 2018 File No. 333-224800
Dear Mr. Uecker :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Caleb French at (202) 551 -6947 with any questions.
Sincerely,
/s/ Caleb French for
Show Raw Text
Mail Stop 3030 May 16, 2018 Via E -mail Darrin R. Uecker President and Chief Executive Officer Pulse Biosciences, Inc. 3957 Point Eden Way Hayward, CA 94545 Re: Pulse Biosciences, Inc. Registration Statement on Form S-3 Filed May 9, 2018 File No. 333-224800 Dear Mr. Uecker : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Caleb French at (202) 551 -6947 with any questions. Sincerely, /s/ Caleb French for Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: Andrew D. Hoffman, Esq. Wilson Sonsini Goodrich & Rosati, P.C.